American International Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,186
| Closed | -$245K | – | 1671 |
|
|
2024
Q1 | $245K | Sell |
2,186
-18
| -0.8% | -$2.02K | ﹤0.01% | 2034 |
|
|
2023
Q4 | $128K | Buy |
2,204
+103
| +5% | +$5.98K | ﹤0.01% | 2415 |
|
|
2023
Q3 | $66.7K | Buy |
2,101
+169
| +9% | +$5.37K | ﹤0.01% | 2730 |
|
|
2023
Q2 | $159K | Buy |
1,932
+145
| +8% | +$11.9K | ﹤0.01% | 2303 |
|
|
2023
Q1 | $184K | Buy |
1,787
+36
| +2% | +$3.7K | ﹤0.01% | 2162 |
|
|
2022
Q4 | $257K | Buy |
1,751
+39
| +2% | +$5.71K | ﹤0.01% | 2003 |
|
|
2022
Q3 | $289K | Buy |
1,712
+71
| +4% | +$12K | ﹤0.01% | 1925 |
|
|
2022
Q2 | $189K | Buy |
1,641
+220
| +15% | +$25.3K | ﹤0.01% | 2216 |
|
|
2022
Q1 | $142K | Sell |
1,421
-100
| -7% | -$9.99K | ﹤0.01% | 2441 |
|
|
2021
Q4 | $237K | Sell |
1,521
-46
| -3% | -$7.17K | ﹤0.01% | 2267 |
|
|
2021
Q3 | $369K | Buy |
1,567
+23
| +1% | +$5.42K | ﹤0.01% | 2041 |
|
|
2021
Q2 | $524 | Buy |
1,544
+303
| +24% | +$103 | ﹤0.01% | 1893 |
|
|
2021
Q1 | $502 | Buy |
1,241
+3
| +0.2% | +$1 | ﹤0.01% | 1840 |
|
|
2020
Q4 | $823 | Sell |
1,238
-35
| -3% | -$23 | ﹤0.01% | 1499 |
|
|
2020
Q3 | $593K | Buy |
1,273
+151
| +13% | +$70.3K | ﹤0.01% | 1511 |
|
|
2020
Q2 | $656K | Buy |
1,122
+272
| +32% | +$159K | ﹤0.01% | 1456 |
|
|
2020
Q1 | $124K | Sell |
850
-50
| -6% | -$7.29K | ﹤0.01% | 2188 |
|
|
2019
Q4 | $129K | Sell |
900
-7
| -0.8% | -$1K | ﹤0.01% | 2476 |
|
|
2019
Q3 | $36K | Sell |
907
-6
| -0.7% | -$238 | ﹤0.01% | 2960 |
|
|
2019
Q2 | $92K | Buy |
913
+592
| +184% | +$59.7K | ﹤0.01% | 2726 |
|
|
2019
Q1 | $42K | Sell |
321
-11
| -3% | -$1.44K | ﹤0.01% | 2919 |
|
|
2018
Q4 | $34K | Sell |
332
-2
| -0.6% | -$205 | ﹤0.01% | 2963 |
|
|
2018
Q3 | $84K | Buy |
334
+9
| +3% | +$2.26K | ﹤0.01% | 2918 |
|
|
2018
Q2 | $145K | Buy |
325
+39
| +14% | +$17.4K | ﹤0.01% | 2561 |
|
|
2018
Q1 | $113K | Buy |
286
+150
| +110% | +$59.3K | ﹤0.01% | 2595 |
|
|
2017
Q4 | $56K | Buy |
136
+7
| +5% | +$2.88K | ﹤0.01% | 2923 |
|
|
2017
Q3 | $56K | Buy |
+129
| New | +$56K | ﹤0.01% | 2789 |
|